Biotech Values

[Biowatch]

Panel rejects ABT's Xinlay

http://yahoo.reuters.com/financeQuoteCompanyNewsArticle.jhtml?duid=mtfh86366_2005-09-13_16-00-07_wat...

>>US FDA panel rejects Abbott prostate cancer drug
Tue Sep 13, 2005 12:00 PM ET

BETHESDA, Md., Sept 13 (Reuters) - Abbott Laboratories Inc.'s (ABT.N: Quote, Profile, Research) experimental drug Xinlay should not be approved for treating men with advanced prostate cancer, a U.S. advisory panel unanimously said on Tuesday.

The Food and Drug Administration will make the final decision, but the agency usually follows recommendations from advisory panels.<<